Member Exclusive

Novel epigenetic therapy to treat mantle cell lymphoma

Scientists at Bellvitge Biomedical Research Institute have developed a small molecule epigenetic drug, targeting HDAC6, which could slow down cell growth in mantle cell lymphoma.

Go to the profile of Jasmine Harris
Jun 13, 2018

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.